AxSpA Physiotherapy Academy 2021 Clinical Presentation – SpeakersCathy Ogden2021-03-16T10:10:36+00:00
Professor Karl Gaffney - MBBChBAO(Hons) FRCPI FRCP
Consultant Rheumatologist, Norfolk & Norwich University Hospital
Professor Karl Gaffney (MB, BCh, BAO Hons, FRCPI, FRCP) has been a Consultant Rheumatologist in Norwich since 1995 where he is service lead for axial
spondyloarthritis (including ankylosing spondylitis), adolescent rheumatology and osteoporosis. He is an Honorary Professor at Norwich Medical School, chair of the medical advisory board, National Axial Spondyloarthritis Society (www.nass.co.uk), founder member, treasurer and chair-elect of BRITSpA www.britspa.co.uk), chair of the British Society for Rheumatology (BSR) axial SpA Biologics Guidelines Committee, member of the National Early Inflammatory Arthritis Project Working Group, vice-chair of the BSR Heberden Committee, co-director and founder of the East of England and London Spondyloarthritis Academy (www.spaacademy.org), and an invited member of the Assessment of Spondyloarthritis International Society www.asas-group.org.
He has also represented the BSR and NASS at the National Institute for Health and Care Excellence (NICE) appraisal of biological therapies since 2007. He was Rheumatology Service Director from 2008 until 2016, Director of Postgraduate Education in Norwich between 1999 and 2005, and Director of Rheumatology Training, Eastern Deanery between 2001 and 2007.
With NASS he has co-developed primary and secondary care educational programmes for healthcare professionals. These initiatives have been awarded national and European awards for excellence in healthcare communication. He is leading the NASS National Gold Standard Delay to Diagnosis project, launched at the House of Commons in July 2020 www.nass.co.uk/get-involved/gold-standard. His current research interests include epidemiology, dose optimisation and extra-articular manifestations of axial SpA. He oversees a large clinical trials programme and collaborates with other national and international centres. He has published extensively and has been an invited speaker at national and international meetings.
Consultant Rheumatologist, Cambridge University Hospitals
Dr Deepak Jadon is a consultant rheumatologist, Director of the Rheumatology Research Unit, and lead for psoriatic arthritis (PsA) at Addenbrooke’s Hospital, Cambridge.
Having grown up in Cardiff, he graduated from the University of Wales College of Medicine in 2003, and then undertook clinical training in rheumatology and general internal medicine in Bath and Bristol between 2007-2015. He completed his PhD thesis on ‘biomarkers of psoriatic arthritis phenotypes’ at the Royal National Hospital for Rheumatic Diseases (Bath, UK) in 2015.
Deepak has particular expertise in the investigation and management of psoriatic arthritis (PsA), ankylosing spondylitis (AS), spondyloarthritis (SpA) and rheumatoid arthritis (RA). He is qualified in the use of musculoskeletal ultrasound.
Deepak is Director of the Rheumatology Research Unit at Cambridge University Hospitals NHSFT (Addenbrooke’s Hospital), where he leads a team of 5 research nurses, 3 rheumatology fellows, and 2 administrators. They are currently performing >20 clinical trials / studies of novel cutting-edge medications for the treatment of arthritis and other rheumatological diseases.
He is an Associate Principal Investigator in the Department of Medicine at the University of Cambridge. His research interests include genetic and serum biomarkers of PsA, AS and SpA, in particular those that predict prognosis.
Deepak is Theme Lead for E-learning at the University of Cambridge Clinical School, delivering high quality online learning to year 4-6 medical student.
Advanced Musculoskeletal First Contact Physiotherapist, Sirona Care & Health
Chris graduated from the University of East Anglia’s pre-registration Physiotherapy Masters cohort after completing an undergraduate degree in Sport and Exercise Science. He undertook his junior NHS Physiotherapy rotations in Buckinghamshire Healthcare Trust and in Bath at the Royal United Hospital. He later took up a Senior Physiotherapist post in a specialist tertiary care Rheumatology setting at the Royal National Hospital for Rheumatic Diseases, Bath. Here, Chris honed his skills and found his love of Rheumatology. He worked with inpatient and outpatient Rheumatology patients and was a lead on their prestigious Axial Spondyloarthritis 2-week residential programme, working alongside the multi-disciplinary team.
Chris now works as an Advanced Musculoskeletal First Contact Physiotherapist (FCP) in primary care in the South West of England and has a passion for health advocacy, leadership and policy. He sits on the Board of Trustees for the Arthritis and Musculoskeletal Alliance (ARMA, http://arma.uk.net/), which is an umbrella body bringing together patient organisations and professional bodies representing the breadth of musculoskeletal health.
Chris has maintained a specialist interest in Rheumatology, particularly Spondyloarthritis, and has presented nationally on this topic as well as published in this field. Chris has been an elected Executive Committee member on the British Society for Spondyloarthritis (BRITSpA, https://britspa.co.uk/) since 2019; a charity of healthcare professionals dedicated to advancing knowledge and treatment of Spondyloarthritis, and his research interests lie within the non-pharmacological management of Rheumatic and Musculoskeletal Diseases (RMDs). Chris is keen to advance and contribute to research priorities within RMDs and he is an active member on Versus Arthritis’ Adult Inflammatory Arthritis Research Advisory Group